# Preventive VT Substrate Ablation in Ischemic Heart Disease

> **NCT04675073** · PHASE3 · UNKNOWN · sponsor: **Centro Medico Teknon** · enrollment: 58 (estimated)

## Conditions studied

- Ventricular Tachycardia
- Ventricular Arrythmia
- Sudden Cardiac Death
- Sudden Cardiac Death Due to Cardiac Arrhythmia
- Ischemic Heart Disease
- Myocardial Infarction
- Magnetic Resonance Imaging

## Interventions

- **PROCEDURE:** Ventricular tachycardia substrate-based radiofrequency ablation

## Key facts

- **NCT ID:** NCT04675073
- **Lead sponsor:** Centro Medico Teknon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04675073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04675073, "Preventive VT Substrate Ablation in Ischemic Heart Disease". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04675073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*